BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 45130)

  • 1. Serum prolactin levels following intramuscular chlorpromazine: two- and three-hour response as predictors of six-hour response.
    Busch DA; Fang VS; Meltzer HY
    Psychiatry Res; 1979 Oct; 1(2):153-9. PubMed ID: 45130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls.
    Meltzer HY; Busch DA; Creese IR; Snyder SH; Fang VS
    Psychiatry Res; 1981 Aug; 5(1):95-105. PubMed ID: 6944710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine tests during treatment with neuroleptic drugs: I. Plasma prolactin response to chlorpromazine challenge.
    Kolakowska T; Fraser S; Franklin M; Knox J
    Psychopharmacology (Berl); 1981; 72(3):283-5. PubMed ID: 6111824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin secretion response to TRH stimulation in acute and chronic schizophrenic patients under neuroleptic treatment.
    Cabranes JA; Fuentenebro F; Recio MN; Borque M; Almoguera MI
    Int Pharmacopsychiatry; 1982; 17(1):1-7. PubMed ID: 6123489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
    Kolakowska T; Wiles DH; Gelder MG; McNeilly AS
    Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response.
    Meltzer HY; Busch DA; Fang VS
    Psychiatry Res; 1983 Aug; 9(4):271-83. PubMed ID: 6580660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High plasma prolactin levels after long-term neuroleptic treatment.
    Zelaschi NM; Delucchi GA; Rodriguez JL
    Biol Psychiatry; 1996 May; 39(10):900-1. PubMed ID: 8860193
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum prolactin response to chlorpromazine and psychopathology in schizophrenics: implications for the dopamine hypothesis.
    Meltzer HY; Busch D
    Psychiatry Res; 1983 Aug; 9(4):285-99. PubMed ID: 6580661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin levels and effects of neuroleptics.
    Brown WA
    Psychosomatics; 1983 Jun; 24(6):569-74, 577-81. PubMed ID: 6136065
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
    Chouinard G; Annable L; Jones BD; Collu R
    Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients.
    Kolakowska T; Wiles DH; McNeilly AS; Gelder MG
    Psychol Med; 1975 May; 5(2):214-6. PubMed ID: 240179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of clozapine on human serum prolactin levels.
    Meltzer HY; Goode DJ; Schyve PM; Young M; Fang VS
    Am J Psychiatry; 1979 Dec; 136(12):1550-5. PubMed ID: 507205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study.
    Kolakowska T; Orr M; Gelder M; Heggie M; Wiles D; Franklin M
    Br J Psychiatry; 1979 Oct; 135():352-9. PubMed ID: 519119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin shifts after neuroleptic withdrawal.
    Green AI; Faraone SV; Brown WA
    Psychiatry Res; 1990 Jun; 32(3):213-9. PubMed ID: 1975101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of serum prolactin levels in schizophrenia: comparison of males and females.
    Kuruvilla A; Peedicayil J; Srikrishna G; Kuruvilla K; Kanagasabapathy AS
    Clin Exp Pharmacol Physiol; 1992 Sep; 19(9):603-6. PubMed ID: 1356671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to the prolactin-elevating effect of neuroleptics.
    Brown WA; Laughren TP
    Psychiatry Res; 1981 Dec; 5(3):317-22. PubMed ID: 6119716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between serum testosterone levels, body mass index (BMI) and insulin in male patients with schizophrenia treated with atypical antipsychotics--olanzapine or risperidone.
    Konarzewska B; Galińska-Skok B; Waszkiewicz N; Łazarczyk-Kirejczyk J; Malus A; Simonienko K; Szulc A
    Neuro Endocrinol Lett; 2014; 35(1):50-7. PubMed ID: 24625910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV; Brown WA; Laughren TP
    J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daytime variation in serum prolactin level in patients receiving oral and depot antipsychotic medication.
    Goode DJ; Meltzer HY; Fang VS
    Biol Psychiatry; 1981 Jul; 16(7):653-62. PubMed ID: 7196775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment.
    Wiles DH; Kolakowska T; McNeilly AS; Mandelbrote BM; Gelder MG
    Psychol Med; 1976 Aug; 6(3):407-15. PubMed ID: 996201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.